bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Table 2 from Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity
Authors: Zhang Xiuli , Kim Samuel , Hundal Jasreet , Herndon John M. , Li Shunqiang , Petti Allegra A. , Soysal Savas D. , Li Lijin , McLellan Mike D. , Hoog Jeremy , Primeau Tina , Myers Nancy , Vickery Tammi L. , Sturmoski Mark , Hagemann Ian S. , Miller Chris A. , Ellis Matthew J. , Mardis Elaine R. , Hansen Ted , Fleming Timothy P. , Goedegebuure S. Peter , Gillanders William E.
Published: April 2023

Characterization of tier 1 mutations identified in WHIM30 through NSG.
Supplementary Figure Legends from NK Cell–Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by Cytokines
Authors: Jaime-Ramirez Alena C. , McMichael Elizabeth L. , Kondadasula SriVidya , Skinner Cassandra C. , Mundy-Bosse Bethany L. , Luedke Eric , Jones Natalie B. , Mani Aruna , Roda Julie , Karpa Volodymyr , Li Hong , Li Jilong , Elavazhagan Saranya , La Perle Krista M. , Schmitt Alessandra C. , Lu Yanhui , Zhang Xiaoli , Pan Xueliang , Mao Hsaioyin , Davis Melanie , Jarjoura David , Butchar Jonathan P. , Poi Ming , Phelps Mitch , Tridandapani Susheela , Byrd John C. , Caligiuri Michael A. , Lee Robert J. , Carson William E.
Published: April 2023

Supplementary Figure Legends
Supplemental Table 2 from Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma
Authors: Callea Marcella , Albiges Laurence , Gupta Mamta , Cheng Su-Chun , Genega Elizabeth M. , Fay André P. , Song Jiaxi , Carvo Ingrid , Bhatt Rupal S. , Atkins Michael B. , Hodi F. Stephen , Choueiri Toni K. , McDermott David F. , Freeman Gordon J. , Signoretti Sabina
Published: April 2023

PD-L1 positivity in relation to tumor grade within individual lesions.
Supplemental Table 1 from Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma
Authors: Callea Marcella , Albiges Laurence , Gupta Mamta , Cheng Su-Chun , Genega Elizabeth M. , Fay André P. , Song Jiaxi , Carvo Ingrid , Bhatt Rupal S. , Atkins Michael B. , Hodi F. Stephen , Choueiri Toni K. , McDermott David F. , Freeman Gordon J. , Signoretti Sabina
Published: April 2023

Time interval between the resection of the primary tumor and the resection of each metastatic lesion. The discordance in PD-L1 expression between the primary tumor and each metastasis is also noted.
Supplementary Data from Complex Immune Evasion Strategies in Classical Hodgkin Lymphoma
Authors: Wein Frederik , Weniger Marc A. , Höing Benedikt , Arnolds Judith , Hüttmann Andreas , Hansmann Martin-Leo , Hartmann Sylvia , Küppers Ralf
Published: April 2023

Supplemental Figure 1 - Representative examples of the histochemistry assay to measure CD73 activity as summarized in Fig. 4D). A 4x objective lens was used to evaluate intensity of dark precipitate correlating with CD73 specific 5â€²-nucleotidase enzymatic activity. Supplemental Table 1
Supplementary figure legends from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
Authors: Alkayyal Almohanad A. , Tai Lee-Hwa , Kennedy Michael A. , de Souza Christiano Tanese , Zhang Jiqing , Lefebvre Charles , Sahi Shalini , Ananth Abhirami A. , Mahmoud Ahmad Bakur , Makrigiannis Andrew P. , Cron Greg O. , Macdonald Blair , Marginean E. Celia , Stojdl David F. , Bell John C. , Auer Rebecca C.
Published: April 2023

Supplementary figure legends
Supplementary Fig. S.5 from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
Authors: Alkayyal Almohanad A. , Tai Lee-Hwa , Kennedy Michael A. , de Souza Christiano Tanese , Zhang Jiqing , Lefebvre Charles , Sahi Shalini , Ananth Abhirami A. , Mahmoud Ahmad Bakur , Makrigiannis Andrew P. , Cron Greg O. , Macdonald Blair , Marginean E. Celia , Stojdl David F. , Bell John C. , Auer Rebecca C.
Published: April 2023

In vitro comparison of IL-12 expression levels from G-less MRB-IL12-ICV and MG1-IL12-ICV.
Supplementary Fig. S.4 from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
Authors: Alkayyal Almohanad A. , Tai Lee-Hwa , Kennedy Michael A. , de Souza Christiano Tanese , Zhang Jiqing , Lefebvre Charles , Sahi Shalini , Ananth Abhirami A. , Mahmoud Ahmad Bakur , Makrigiannis Andrew P. , Cron Greg O. , Macdonald Blair , Marginean E. Celia , Stojdl David F. , Bell John C. , Auer Rebecca C.
Published: April 2023

Intra-tumoral vaccination is essential to maximize the benefit of MG1-IL12-ICV vaccine.
Supplementary Figure 3 from Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
Authors: Jeanbart Laura , Ballester Marie , de Titta Alexandre , Corthésy Patricia , Romero Pedro , Hubbell Jeffrey A. , Swartz Melody A.
Published: April 2023

PDF file - 23K, Targeting the tdLN with NP-TRP-2 + free CpG is therapeutically more beneficial than targeting a non-tdLN.
Supplementary Fig. S.2 from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
Authors: Alkayyal Almohanad A. , Tai Lee-Hwa , Kennedy Michael A. , de Souza Christiano Tanese , Zhang Jiqing , Lefebvre Charles , Sahi Shalini , Ananth Abhirami A. , Mahmoud Ahmad Bakur , Makrigiannis Andrew P. , Cron Greg O. , Macdonald Blair , Marginean E. Celia , Stojdl David F. , Bell John C. , Auer Rebecca C.
Published: April 2023

Supplementary figure S.2: Viral fitness, kinetics and tumour cytotoxicity.
Supplemental Figure Legends from Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade
Authors: Curran Shane A. , Shyer Justin A. , St. Angelo Erin T. , Talbot Lillian R. , Sharma Sneh , Chung David J. , Heller Glenn , Hsu Katharine C. , Betts Brian C. , Young James W.
Published: April 2023

Supplemental article file
Supplemental Figure 3 from Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade
Authors: Curran Shane A. , Shyer Justin A. , St. Angelo Erin T. , Talbot Lillian R. , Sharma Sneh , Chung David J. , Heller Glenn , Hsu Katharine C. , Betts Brian C. , Young James W.
Published: April 2023

moDC stimulated NK cells retain surface expression of the gamma chain receptor despite the presence of JAK inhibitors.
supplementary table 2 from Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells
Authors: Wang Hao-Chen , Chen Chin-Wang , Yang Chia-Lung , Tsai I-Min , Hou Ya-Chin , Chen Chang-Jung , Shan Yan-Shen
Published: April 2023

Table S2. Expression of DNMT1 in 121 gastric tumors according to tumor stages
Supplementary Figure 1 from Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141+ Dendritic Cells and Enhanced Cross-Presentation
Authors: Sluijter Berbel J.R. , van den Hout Mari F.C.M. , Koster Bas D. , van Leeuwen Paul A.M. , Schneiders Famke L. , van de Ven Rieneke , Molenkamp Barbara G. , Vosslamber Saskia , Verweij Cornelis L. , van den Tol M. Petrousjka , van den Eertwegh Alfons J.M. , Scheper Rik J. , de Gruijl Tanja D.
Published: April 2023

Gating strategies for analysis of A) plasmacytoid DC (pDC) and B) skin-migratory conventional DC (cDC) subsets: Dermal DC (DDC) and Langerhans Cells (LC) and C) LN-resident cDC subsets in melanoma Sentinel Lymph Nodes (SLN).
Supplementary Figures from Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice
Authors: Galliverti Gabriele , Tichet Mélanie , Domingos-Pereira Sonia , Hauert Sylvie , Nardelli-Haefliger Denise , Swartz Melody A. , Hanahan Douglas , Wullschleger Stephan
Published: April 2023

Supplementary Figures
Supplementary Figures 1 - 4 from Exosomes Associated with Human Ovarian Tumors Harbor a Reversible Checkpoint of T-cell Responses
Authors: Shenoy Gautam N. , Loyall Jenni , Maguire Orla , Iyer Vandana , Kelleher Raymond J. , Minderman Hans , Wallace Paul K. , Odunsi Kunle , Balu-Iyer Sathy V. , Bankert Richard B.
Published: April 2023

S1: Exosome derived from different ascites fluids show varying degrees of inhibition. S2: Exosomes do not affect T cell death following activation. S3: Exosomes inhibit IL-2 production by T cells. S4: Exosomes inhibit IFN-gamma production by T cells.
Supplementary Figure legends from Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
Authors: Christmas Brian J. , Rafie Christine I. , Hopkins Alexander C. , Scott Blake A. , Ma Hayley S. , Cruz Kayla A. , Woolman Skylar , Armstrong Todd D. , Connolly Roisin M. , Azad Nilo A. , Jaffee Elizabeth M. , Roussos Torres Evanthia T.
Published: April 2023

Supplementary figure legends (S1-S11) clean AND supplementary table legends (1-2) clean.
Figure S6 from Sustained Type I Interferon Reinforces NK Cell–Mediated Cancer Immunosurveillance during Chronic Virus Infection
Authors: Oh Ji Hoon , Kim Myeong Joon , Choi Seong Jin , Ban Young Ho , Lee Heung Kyu , Shin Eui-Cheol , Lee Kyung-Mi , Ha Sang-Jun
Published: April 2023

Figure S6. shows that there is no direct antitumor effect by LCMV replication.
Figure S3 from Sustained Type I Interferon Reinforces NK Cell–Mediated Cancer Immunosurveillance during Chronic Virus Infection
Authors: Oh Ji Hoon , Kim Myeong Joon , Choi Seong Jin , Ban Young Ho , Lee Heung Kyu , Shin Eui-Cheol , Lee Kyung-Mi , Ha Sang-Jun
Published: April 2023

Figure S3. shows the analysis of tumor infiltrating lymphocytes in subcutaneous EG7 tumor model.
Supplementary Figures 1-3 from Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL
Authors: Xu-Monette Ziju Y. , Xiao Min , Au Qingyan , Padmanabhan Raghav , Xu Bing , Hoe Nicholas , Rodríguez-Perales Sandra , Torres-Ruiz Raul , Manyam Ganiraju C. , Visco Carlo , Miao Yi , Tan Xiaohong , Zhang Hongwei , Tzankov Alexandar , Wang Jing , Dybkær Karen , Tam Wayne , You Hua , Bhagat Govind , Hsi Eric D. , Ponzoni Maurilio , Ferreri Andrés J.M. , Møller Michael B. , Piris Miguel A. , van Krieken J. Han , Winter Jane N. , Westin Jason R. , Pham Lan V. , Medeiros L. Jeffrey , Rassidakis George Z. , Li Yong , Freeman Gordon J. , Young Ken H.
Published: April 2023

Supplementary Figures S1 to S3
Video 3 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
Authors: Gui Philippe , Ben-Neji Myriam , Belozertseva Ekaterina , Dalenc Florence , Franchet Camille , Gilhodes Julia , Labrousse Arnaud , Bellard Elisabeth , Golzio Muriel , Poincloux Renaud , Maridonneau-Parini Isabelle , Le Cabec Véronique
Published: April 2023

Video 3
Supplementary Fig S5 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
Authors: Gui Philippe , Ben-Neji Myriam , Belozertseva Ekaterina , Dalenc Florence , Franchet Camille , Gilhodes Julia , Labrousse Arnaud , Bellard Elisabeth , Golzio Muriel , Poincloux Renaud , Maridonneau-Parini Isabelle , Le Cabec Véronique
Published: April 2023

supplementary fig S5
Supplementary Fig S4 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
Authors: Gui Philippe , Ben-Neji Myriam , Belozertseva Ekaterina , Dalenc Florence , Franchet Camille , Gilhodes Julia , Labrousse Arnaud , Bellard Elisabeth , Golzio Muriel , Poincloux Renaud , Maridonneau-Parini Isabelle , Le Cabec Véronique
Published: April 2023

supplementary fig S4
Supplemental figure 3 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
Authors: Gui Philippe , Ben-Neji Myriam , Belozertseva Ekaterina , Dalenc Florence , Franchet Camille , Gilhodes Julia , Labrousse Arnaud , Bellard Elisabeth , Golzio Muriel , Poincloux Renaud , Maridonneau-Parini Isabelle , Le Cabec Véronique
Published: April 2023

Supplemental figure 3
Supplemental figure 2 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
Authors: Gui Philippe , Ben-Neji Myriam , Belozertseva Ekaterina , Dalenc Florence , Franchet Camille , Gilhodes Julia , Labrousse Arnaud , Bellard Elisabeth , Golzio Muriel , Poincloux Renaud , Maridonneau-Parini Isabelle , Le Cabec Véronique
Published: April 2023

Supplemental figure 2
Supplemental Table 1 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
Authors: Gui Philippe , Ben-Neji Myriam , Belozertseva Ekaterina , Dalenc Florence , Franchet Camille , Gilhodes Julia , Labrousse Arnaud , Bellard Elisabeth , Golzio Muriel , Poincloux Renaud , Maridonneau-Parini Isabelle , Le Cabec Véronique
Published: April 2023

Supplemental Table 1
Figure S1 from Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites
Authors: Morris Zachary S. , Guy Emily I. , Werner Lauryn R. , Carlson Peter M. , Heinze Clinton M. , Kler Jasdeep S. , Busche Sara M. , Jaquish Abigail A. , Sriramaneni Raghava N. , Carmichael Lakeesha L. , Loibner Hans , Gillies Stephen D. , Korman Alan J. , Erbe Amy K. , Hank Jacquelyn A. , Rakhmilevich Alexander L. , Harari Paul M. , Sondel Paul M.
Published: April 2023

Concomitant immune tolerance prevents an immunotherapeutic response at the distant tumor site, is observed with an 8 Gy x 3 fraction RT regimen, and requires a well-established macroscopic secondary tumor.
Supplementary Table ST1 from PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients
Authors: Concha-Benavente Fernando , Kansy Benjamin , Moskovitz Jessica , Moy Jennifer , Chandran Uma , Ferris Robert L.
Published: April 2023

Supplementary Table 1
Supplementary Figures and Table legends from PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients
Authors: Concha-Benavente Fernando , Kansy Benjamin , Moskovitz Jessica , Moy Jennifer , Chandran Uma , Ferris Robert L.
Published: April 2023

Legends for Supplementary figures and table
Table S1 from Soluble SLAMF6 Receptor Induces Strong CD8+ T-cell Effector Function and Improves Anti-Melanoma Activity In Vivo
Authors: Eisenberg Galit , Engelstein Roni , Geiger-Maor Anat , Hajaj Emma , Merims Sharon , Frankenburg Shoshana , Uzana Ronny , Rutenberg Abraham , Machlenkin Arthur , Frei Gabi , Peretz Tamar , Lotem Michal
Published: April 2023

Tumor infiltrating lymphocytes used in the study
Supplementary Figure S3 from PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients
Authors: Concha-Benavente Fernando , Kansy Benjamin , Moskovitz Jessica , Moy Jennifer , Chandran Uma , Ferris Robert L.
Published: April 2023

Supplementary Figure S3
Supplementary Figure S2 from PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients
Authors: Concha-Benavente Fernando , Kansy Benjamin , Moskovitz Jessica , Moy Jennifer , Chandran Uma , Ferris Robert L.
Published: April 2023

Supplementary Figure S2
Figure S3 from Soluble SLAMF6 Receptor Induces Strong CD8+ T-cell Effector Function and Improves Anti-Melanoma Activity In Vivo
Authors: Eisenberg Galit , Engelstein Roni , Geiger-Maor Anat , Hajaj Emma , Merims Sharon , Frankenburg Shoshana , Uzana Ronny , Rutenberg Abraham , Machlenkin Arthur , Frei Gabi , Peretz Tamar , Lotem Michal
Published: April 2023

Anti-SLAMF6 antibody had no direct effect on T cell activation
Figure S2 from Soluble SLAMF6 Receptor Induces Strong CD8+ T-cell Effector Function and Improves Anti-Melanoma Activity In Vivo
Authors: Eisenberg Galit , Engelstein Roni , Geiger-Maor Anat , Hajaj Emma , Merims Sharon , Frankenburg Shoshana , Uzana Ronny , Rutenberg Abraham , Machlenkin Arthur , Frei Gabi , Peretz Tamar , Lotem Michal
Published: April 2023

SLAMF6 Overlapping-peptide SPOT array showing seSLAMF6 binding sequences
Supplementary Figure S1 from PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients
Authors: Concha-Benavente Fernando , Kansy Benjamin , Moskovitz Jessica , Moy Jennifer , Chandran Uma , Ferris Robert L.
Published: April 2023

Supplementary Figure S1
Supplemental Figures from TUSC2 Immunogene Therapy Synergizes with Anti–PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models
Authors: Meraz Ismail M. , Majidi Mourad , Cao Xiaobo , Lin Heather , Li Lerong , Wang Jing , Baladandayuthapani Veera , Rice David , Sepesi Boris , Ji Lin , Roth Jack A.
Published: April 2023

Supplemental Figures 1-4
Supplementary Table S2 from All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages
Authors: Zhou Qian , Xian Miao , Xiang Senfeng , Xiang Danyan , Shao Xuejing , Wang Jincheng , Cao Ji , Yang Xiaochun , Yang Bo , Ying Meidan , He Qiaojun
Published: April 2023

Supplementary Table S2
Supplementary Table S1 from All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages
Authors: Zhou Qian , Xian Miao , Xiang Senfeng , Xiang Danyan , Shao Xuejing , Wang Jincheng , Cao Ji , Yang Xiaochun , Yang Bo , Ying Meidan , He Qiaojun
Published: April 2023

Supplementary Table S1
Figure S6 from Modulation of Endoplasmic Reticulum Stress Controls CD4+ T-cell Activation and Antitumor Function
Authors: Thaxton Jessica E. , Wallace Caroline , Riesenberg Brian , Zhang Yongliang , Paulos Chrystal M. , Beeson Craig C. , Liu Bei , Li Zihai
Published: April 2023

Cytosolic Ca2+ levels discriminate among human CD4+ T cell populations
Figure S5 from Modulation of Endoplasmic Reticulum Stress Controls CD4+ T-cell Activation and Antitumor Function
Authors: Thaxton Jessica E. , Wallace Caroline , Riesenberg Brian , Zhang Yongliang , Paulos Chrystal M. , Beeson Craig C. , Liu Bei , Li Zihai
Published: April 2023

Cytosolic Ca2+ levels discriminate CD8+ T cell population
Supplementary Figure 1 from IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer
Authors: Mirlekar Bhalchandra , Michaud Daniel , Searcy Ryan , Greene Kevin , Pylayeva-Gupta Yuliya
Published: April 2023

This figure demonstrates that host deficiency for IL-35 does not affect myeloid cell frequency
Figure S1 from Modulation of Endoplasmic Reticulum Stress Controls CD4+ T-cell Activation and Antitumor Function
Authors: Thaxton Jessica E. , Wallace Caroline , Riesenberg Brian , Zhang Yongliang , Paulos Chrystal M. , Beeson Craig C. , Liu Bei , Li Zihai
Published: April 2023

ER stress chaperone grp78 is upregulated in response to TCR stimulation
Supplementary Figure Legends from A Mechanism of Resistance to Antibody-Targeted Immune Attack
Authors: Aldeghaither Dalal S. , Zahavi David J. , Murray Joseph C. , Fertig Elana J. , Graham Garrett T. , Zhang Yong-Wei , O'Connell Allison , Ma Junfeng , Jablonski Sandra A. , Weiner Louis M.
Published: April 2023

Legends for Supplemental Figures 1-7 in Supplementary Data file
Supplementary Data from Tumor Lymphatic Function Regulates Tumor Inflammatory and Immunosuppressive Microenvironments
Authors: Kataru Raghu P. , Ly Catherine L. , Shin Jinyeon , Park Hyeung Ju , Baik Jung Eun , Rehal Sonia , Ortega Sagrario , Lyden David , Mehrara Babak J.
Published: April 2023

Figure S1, S2, S3, S4, S5, S6 and S7
Supplementary Figure 4 from The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade
Authors: Li Howard Y. , McSharry Maria , Bullock Bonnie , Nguyen Teresa T. , Kwak Jeff , Poczobutt Joanna M. , Sippel Trisha R. , Heasley Lynn E. , Weiser-Evans Mary C. , Clambey Eric T. , Nemenoff Raphael A.
Published: April 2023

Silencing of PD-L1 in CMT167 cells using shRNA
Table S1 from TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway
Authors: Zizzari Ilaria Grazia , Napoletano Chiara , Botticelli Andrea , Caponnetto Salvatore , Calabrò Fabio , Gelibter Alain , Rughetti Aurelia , Ruscito Ilary , Rahimi Hassan , Rossi Ernesto , Schinzari Giovanni , Marchetti Paolo , Nuti Marianna
Published: April 2023

MoAbs used in this study
Supplementary Figure 3 from YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
Authors: Kim Min Hwan , Kim Chang Gon , Kim Sang-Kyum , Shin Sang Joon , Choe Eun Ah , Park Su-Hyung , Shin Eui-Cheol , Kim Joon
Published: April 2023

S3. Analysis of BRAFi-resistant melanoma cells.
Supplementary Table S2 from Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations
Authors: Veatch Joshua R. , Jesernig Brenda L. , Kargl Julia , Fitzgibbon Matthew , Lee Sylvia M. , Baik Christina , Martins Renato , Houghton A. McGarry , Riddell Stanley R.
Published: April 2023

Supplementary Table S2
Fragale et al_Supplementary Figure S3_CIR from Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells
Authors: Fragale Alessandra , Romagnoli Giulia , Licursi Valerio , Buoncervello Maria , Del Vecchio Giorgia , Giuliani Caterina , Parlato Stefania , Leone Celeste , De Angelis Marta , Canini Irene , Toschi Elena , Belardelli Filippo , Negri Rodolfo , Capone Imerio , Presutti Carlo , Gabriele Lucia
Published: April 2023

Supplementary Figure 3 Biological processes categories enriched in the list of genes showing H3K9me2 peaks in the promoter region.
Supplementary Figures from Mechanisms by Which Dendritic Cells Present Tumor Microparticle Antigens to CD8+ T Cells
Authors: Ma Jingwei , Wei Keke , Zhang Huafeng , Tang Ke , Li Fei , Zhang Tianzhen , Liu Junwei , Xu Pingwei , Yu Yuandong , Sun Weiwei , Zhu LiYan , Chen Jie , Zhou Li , Liang Xiaoyu , Lv Jiadi , Fiskesund Roland , Liu Yuying , Huang Bo
Published: April 2023

Supplementary Figures
Supplementary Figure S5 from Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance
Authors: Hennequart Marc , Pilotte Luc , Cane Stefania , Hoffmann Delia , Stroobant Vincent , Plaen Etienne De , Eynde Benoît J. Van den
Published: April 2023

In silico analysis of the CCLE database.
Supplementary Figure 2 from Drug-Induced Senescent Multiple Myeloma Cells Elicit NK Cell Proliferation by Direct or Exosome-Mediated IL15 Trans-Presentation
Authors: Borrelli Cristiana , Ricci Biancamaria , Vulpis Elisabetta , Fionda Cinzia , Ricciardi Maria Rosaria , Petrucci Maria Teresa , Masuelli Laura , Peri Agnese , Cippitelli Marco , Zingoni Alessandra , Santoni Angela , Soriani Alessandra
Published: April 2023

Fig S2. MM patientsâ€™ malignant PCs treated with Bortezomib and Lenalidomide do not express augmented levels of the IL-15/IL-15RA complex
Supplementary Figure S3 from Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance
Authors: Hennequart Marc , Pilotte Luc , Cane Stefania , Hoffmann Delia , Stroobant Vincent , Plaen Etienne De , Eynde Benoît J. Van den
Published: April 2023

Effect of PI3K inhibitors on COX-2 expression in KUL98-MELA cells
Supplementary Figure S2 from Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance
Authors: Hennequart Marc , Pilotte Luc , Cane Stefania , Hoffmann Delia , Stroobant Vincent , Plaen Etienne De , Eynde Benoît J. Van den
Published: April 2023

Controls for the activity of PI3K, mTOR and MAPK inhibitors.
Supplementary sequence data from Introduction of Genetically Modified CD3ζ Improves Proliferation and Persistence of Antigen-Specific CTLs
Authors: Miyao Kotaro , Terakura Seitaro , Okuno Shingo , Julamanee Jakrawadee , Watanabe Keisuke , Hamana Hiroshi , Kishi Hiroyuki , Sakemura Reona , Koyama Daisuke , Goto Tatsunori , Nishida Tetsuya , Murata Makoto , Kiyoi Hitoshi
Published: April 2023

Sequence data of CD3zeta and ATAM
Supplemental Methods from Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell–Effector Responses
Authors: Clancy-Thompson Eleanor , Devlin Christine A. , Tyler Paul M. , Servos Mariah M. , Ali Lestat R. , Ventre Katherine S. , Bhuiyan M. Aladdin , Bruck Patrick T. , Birnbaum Michael E. , Dougan Stephanie K.
Published: April 2023

Supplemental Methods
Table S5 from Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort
Authors: Iorgulescu J. Bryan , Harary Maya , Zogg Cheryl K. , Ligon Keith L. , Reardon David A. , Hodi F. Stephen , Aizer Ayal A. , Smith Timothy R.
Published: April 2023

table s5
Table S2 from Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort
Authors: Iorgulescu J. Bryan , Harary Maya , Zogg Cheryl K. , Ligon Keith L. , Reardon David A. , Hodi F. Stephen , Aizer Ayal A. , Smith Timothy R.
Published: April 2023

table s2
Table S1 from Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort
Authors: Iorgulescu J. Bryan , Harary Maya , Zogg Cheryl K. , Ligon Keith L. , Reardon David A. , Hodi F. Stephen , Aizer Ayal A. , Smith Timothy R.
Published: April 2023

Table S1
Figure S2 from TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors
Authors: Francica Brian J. , Ghasemzadeh Ali , Desbien Anthony L. , Theodros Debebe , Sivick Kelsey E. , Reiner Gabrielle L. , Hix Glickman Laura , Marciscano Ariel E. , Sharabi Andrew B. , Leong Meredith L. , McWhirter Sarah M. , Dubensky Thomas W. , Pardoll Drew M. , Drake Charles G.
Published: April 2023

S2: CDN injection causes a distinct cytokine and cellular profile in the tumor draining lymph nodes.
Supplemental Data from Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
Authors: Ghassemi Saba , Nunez-Cruz Selene , O'Connor Roddy S. , Fraietta Joseph A. , Patel Prachi R. , Scholler John , Barrett David M. , Lundh Stefan M. , Davis Megan M. , Bedoya Felipe , Zhang Changfeng , Leferovich John , Lacey Simon F. , Levine Bruce L. , Grupp Stephan A. , June Carl H. , Melenhorst J. Joseph , Milone Michael C.
Published: April 2023

Table S1 and Figures S1 -S8
Supplementary Table S5 from Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients
Authors: Ly Dalam , Zhu Chang-Qi , Cabanero Michael , Tsao Ming-Sound , Zhang Li
Published: April 2023

The 9-gene signature genes and biological descriptions
Figures S1-S11 from Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies
Authors: Mamonkin Maksim , Mukherjee Malini , Srinivasan Madhuwanti , Sharma Sandhya , Gomes-Silva Diogo , Mo Feiyan , Krenciute Giedre , Orange Jordan S. , Brenner Malcolm K.
Published: April 2023

S1. Lack of functional exhaustion in expanding 28.z CD5 CAR T cells. S2. (A) Schematic representation of 28.z CD5 CARs with intermediate (CH3) and short spacer. (B) Expression level of CD5 CARs measured by flow cytometry using anti-mouse F(ab)-specific antibodies. (C) Expansion of T cells transduced with the 28.z CD5 CARs or BB.z CD5 CAR. Data are shown as mean and SD, n=3. S3. Relative frequency of CD45RA+ CCR7+ naïve-like (TNAIVE) and CD45RA- CCR7+ central memory (TCM) cells among T cells expressing indicated CD5 CAR constructs. Data are shown as mean and SD, n=3. S4. Reduced phosphorylation of IKKa/b in CD5 CAR T cells with mutant 4-1BB endodomain. S5. Relative frequency of CD45RA+ CCR7+ naïve-like (TNAIVE) and CD45RA- CCR7+ central memory (TCM) cells among T cells expressing indicated CD5 CAR constructs. Data are shown as mean and SD, n=3. S6. Morphology of T cells expressing indicated CAR constructs 5 days post-transduction. S7. (A) Expression of BB.z CD5 CAR in T cells transduced with retroviral (RV) or lentiviral (LV) vector. (B) Viability of BB.z CD5 CAR T cells 7 days post-transduction. (C) Expression of ICAM-1 on the surface of BB.z CD5 CAR T cells 7 days post-transduction. (D) In vivo control of systemic leukemia by 28.z and BB.z CD5 CAR T cells. (***, P<0.001 by one-way ANOVA with Bonferroni post-test correction). S8. Minimal CAR expression in the presence of DOX is insufficient to promote T-cell cytotoxicity. S9. Reciprocal expression of CD5 and CD5 CAR in Tet-OFF BB.z CD5 CAR T cells after DOX withdrawal. S10. Expansion (A), phenotype (B) and anti-tumor function of Tet-OFF 28.z CD5 CAR T cells in vitro (C). (D) CD5 CAR T cells were injected i.v. into mice with previously established systemic Jurkat leukemia (1x10^6 cells per mouse). Leukemia progression was monitored by IVIS imaging. S11. (A) CD5 CAR T cells with repressed (+DOX) or restored (-DOX) expression of BB.z CD5 CAR were injected i.v. into mice with previously established systemic Jurkat leukemia (1x10^6 cells per mouse). Leukemia progression was monitored by IVIS imaging. (B) Tumor levels in mice on day 34 post-tumor engraftment (*, P,0.05 by one-way ANOVA with Bonferroni post-test correction).
Figure S1 from Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients
Authors: Ly Dalam , Zhu Chang-Qi , Cabanero Michael , Tsao Ming-Sound , Zhang Li
Published: April 2023

Supplementary univariate analysis of Mast cell specific genes
Supplementary Figures from A Multikinase and DNA-PK Inhibitor Combination Immunomodulates Melanomas, Suppresses Tumor Progression, and Enhances Immunotherapies
Authors: Tsai Alexander K. , Khan Asra Y. , Worgo Christina E. , Wang Lucy L. , Liang Yuanyuan , Davila Eduardo
Published: April 2023

Fig. S1: SC200 library HTS candidate drugs. Fig. S2: Effects of EGFR, VEGFR, MEK, and p38 candidate inhibitors on PD-L1 and HLA-I in a melanoma panel and on T-cell proliferation. Fig. S3: Effects of BRAF, PI3K, mTOR, and Src candidate inhibitors on PD-L1 and HLA-I in a melanoma panel and on T-cell proliferation. Fig. S4: Immunomodulatory molecules are up- and down-regulated in melanoma by combination Reg plus NU treatment. Fig. S5: Expression, representative examples of drug-induced changes, and stratification of magnitudes of change in PD-L1. Fig. S6: Representative examples of synergistic, additive, and antagonistic effects. Fig. S7: Expression and stratification of magnitudes of change of CD155. Fig. S8: Expression and stratification of magnitudes of change of HLA-I. Fig. S9: Expression and stratification of magnitudes of change of CD73. Fig. S10: Expression and stratification of magnitudes of change of NGFR. Fig. S11: Expression and stratification of magnitudes of change of CD55. Fig. S12: Reg increases melanoma antigen protein levels. Fig. S13: Reg and NU suppress melanoma proliferation. Fig. S14: Reg and NU inhibit MEK and Akt phosphorylation. Figure S15: T cells treated with Reg and NU proliferate normally. Fig S16: Immunophenotyping of CD8+ T cells treated with Reg and/or NU. Fig S17: Representative examples of increased cytokine production in Reg and NU combination treated CD8+ T cells stimulated with anti-CD3, PMA, and ionomycin. Fig S18: Cytokine production is increased in anti-CD3-stimulated CD8+ T cells treated with combination Reg and NU. Fig S19: Reg and NU reduce PD-L1 on B16. Fig. S20: Dendritic cells, macrophages, myeloid-derived suppressor cells, and natural killer cells of the tumor microenvironment are not altered by Reg and NU.
Supplementary Figure S2 from Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
Authors: Dougan Michael , Ingram Jessica R. , Jeong Hee-Jin , Mosaheb Munir M. , Bruck Patrick T. , Ali Lestat , Pishesha Novalia , Blomberg Olga , Tyler Paul M. , Servos Mariah M. , Rashidian Mohammad , Nguyen Quang-De , von Andrian Ulrich H. , Ploegh Hidde L. , Dougan Stephanie K.
Published: April 2023

S2. In vitro killing of IFNγ treated B16-ova cells by activated OT-I T cells is inhibited by PD-L1.
Supplementary Figure S1 from Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
Authors: Dougan Michael , Ingram Jessica R. , Jeong Hee-Jin , Mosaheb Munir M. , Bruck Patrick T. , Ali Lestat , Pishesha Novalia , Blomberg Olga , Tyler Paul M. , Servos Mariah M. , Rashidian Mohammad , Nguyen Quang-De , von Andrian Ulrich H. , Ploegh Hidde L. , Dougan Stephanie K.
Published: April 2023

S1. B3 binds to PD-L1 on multiple tumor types.
Supplementary Figure Legends from Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
Authors: Dougan Michael , Ingram Jessica R. , Jeong Hee-Jin , Mosaheb Munir M. , Bruck Patrick T. , Ali Lestat , Pishesha Novalia , Blomberg Olga , Tyler Paul M. , Servos Mariah M. , Rashidian Mohammad , Nguyen Quang-De , von Andrian Ulrich H. , Ploegh Hidde L. , Dougan Stephanie K.
Published: April 2023

Supplementary Figure Legends from Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
Table S1 from Nanobody–Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses
Authors: Woodham Andrew W. , Cheloha Ross W. , Ling Jingjing , Rashidian Mohammad , Kolifrath Stephen C. , Mesyngier Maia , Duarte Joao N. , Bader Justin M. , Skeate Joseph G. , Da Silva Diane M. , Kast W. Martin , Ploegh Hidde L.
Published: April 2023

Supplemental Table 1
Supplementary Figure 3 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
Authors: Frazao Alexandra , Messaoudene Meriem , Nunez Nicolas , Dulphy Nicolas , Roussin France , Sedlik Christine , Zitvogel Laurence , Piaggio Eliane , Toubert Antoine , Caignard Anne
Published: April 2023

Supplementary Figure 3
Supplementary Figure 8 from NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome
Authors: Guillamón Concepción F. , Martínez-Sánchez María V. , Gimeno Lourdes , Mrowiec Anna , Martínez-García Jerónimo , Server-Pastor Gerardo , Martínez-Escribano Jorge , Torroba Amparo , Ferri Belén , Abellán Daniel , Campillo José A. , Legaz Isabel , López-Álvarez María R. , Moya-Quiles María Rosa , Muro Manuel , Minguela Alfredo
Published: April 2023

Supplementary Figure 8
Supplementary Figure 2 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
Authors: Frazao Alexandra , Messaoudene Meriem , Nunez Nicolas , Dulphy Nicolas , Roussin France , Sedlik Christine , Zitvogel Laurence , Piaggio Eliane , Toubert Antoine , Caignard Anne
Published: April 2023

Supplementary Figure 2
Supplementary Figure 6 from NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome
Authors: Guillamón Concepción F. , Martínez-Sánchez María V. , Gimeno Lourdes , Mrowiec Anna , Martínez-García Jerónimo , Server-Pastor Gerardo , Martínez-Escribano Jorge , Torroba Amparo , Ferri Belén , Abellán Daniel , Campillo José A. , Legaz Isabel , López-Álvarez María R. , Moya-Quiles María Rosa , Muro Manuel , Minguela Alfredo
Published: April 2023

Supplementary Figure 6
Supplementary Figure 4 from NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome
Authors: Guillamón Concepción F. , Martínez-Sánchez María V. , Gimeno Lourdes , Mrowiec Anna , Martínez-García Jerónimo , Server-Pastor Gerardo , Martínez-Escribano Jorge , Torroba Amparo , Ferri Belén , Abellán Daniel , Campillo José A. , Legaz Isabel , López-Álvarez María R. , Moya-Quiles María Rosa , Muro Manuel , Minguela Alfredo
Published: April 2023

Supplementary Figure 4
Figure S1 from Late-Stage Tumor Regression after PD-L1 Blockade Plus a Concurrent OX40 Agonist
Authors: Polesso Fanny , Weinberg Andrew D. , Moran Amy E.
Published: April 2023

Figure S1 shows the synergy between PD-L1 blockade and OX40 agonism in the CT26 tumor model
Supplementary Figures and Tables from Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model
Authors: Narayanan Jayanth S. Shankara , Ray Partha , Hayashi Tomoko , Whisenant Thomas C. , Vicente Diego , Carson Dennis A. , Miller Aaron M. , Schoenberger Stephen P. , White Rebekah R.
Published: April 2023

Supplementary Figures 1-6 and Supplementary Tables 1 and 2.
Supplementary Figures from Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic Leukemia
Authors: Banerjee Priyanka , Zhang Ronghua , Ivan Cristina , Galletti Giovanni , Clise-Dwyer Karen , Barbaglio Federica , Scarfò Lydia , Aracil Miguel , Klein Christian , Wierda William , Plunkett William , Caligaris-Cappio Federico , Gandhi Varsha , Keating Michael J. , Bertilaccio Maria Teresa S.
Published: April 2023

Supplementary Figures S1-S17
Supplementary Table 1 from HPV Epitope Processing Differences Correlate with ERAP1 Allotype and Extent of CD8+ T-cell Tumor Infiltration in OPSCC
Authors: Reeves Emma , Wood Oliver , Ottensmeier Christian H. , King Emma V. , Thomas Gareth J. , Elliott Tim , James Edward
Published: April 2023

Supplementary Table 1
Supplementary Figure legends from HPV Epitope Processing Differences Correlate with ERAP1 Allotype and Extent of CD8+ T-cell Tumor Infiltration in OPSCC
Authors: Reeves Emma , Wood Oliver , Ottensmeier Christian H. , King Emma V. , Thomas Gareth J. , Elliott Tim , James Edward
Published: April 2023

Supplementary Figure legends
Supplementary Figure 1-4 from HPV Epitope Processing Differences Correlate with ERAP1 Allotype and Extent of CD8+ T-cell Tumor Infiltration in OPSCC
Authors: Reeves Emma , Wood Oliver , Ottensmeier Christian H. , King Emma V. , Thomas Gareth J. , Elliott Tim , James Edward
Published: April 2023

Supplementary Figures 1-4
Supplementary Table 1 from The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer
Authors: Hakozaki Taiki , Richard Corentin , Elkrief Arielle , Hosomi Yukio , Benlaïfaoui Myriam , Mimpen Iris , Terrisse Safae , Derosa Lisa , Zitvogel Laurence , Routy Bertrand , Okuma Yusuke
Published: April 2023

Supplementary Table 1
Supplementary Figure 7 from The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer
Authors: Hakozaki Taiki , Richard Corentin , Elkrief Arielle , Hosomi Yukio , Benlaïfaoui Myriam , Mimpen Iris , Terrisse Safae , Derosa Lisa , Zitvogel Laurence , Routy Bertrand , Okuma Yusuke
Published: April 2023

Supplementary Figure 7
Supplementary Figure 2 from The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer
Authors: Hakozaki Taiki , Richard Corentin , Elkrief Arielle , Hosomi Yukio , Benlaïfaoui Myriam , Mimpen Iris , Terrisse Safae , Derosa Lisa , Zitvogel Laurence , Routy Bertrand , Okuma Yusuke
Published: April 2023

Supplementary Figure 2
Video 3 from Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors
Authors: Nagaya Tadanobu , Friedman Jay , Maruoka Yasuhiro , Ogata Fusa , Okuyama Shuhei , Clavijo Paul E. , Choyke Peter L. , Allen Clint , Kobayashi Hisataka
Published: April 2023

Supplementary Video 3. NIR-PIT effect for MOC1 cells. Immediately after exposure to excitation light, cellular swelling, bleb formation, and rupture of vesicles representing necrotic cell death were observed.
Supplemental file for publication from Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA
Authors: Kundu Kiran , Ghosh Susmita , Sarkar Rhitajit , Edri Avishay , Brusilovsky Michael , Gershoni-Yahalom Orly , Yossef Rami , Shemesh Avishai , Soria Jean-Charles , Lazar Vladimir , Joshua Ben-Zion , Campbell Kerry S. , Elkabets Moshe , Porgador Angel
Published: April 2023

Figure legends for supplemental figure
Video 2 from Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors
Authors: Nagaya Tadanobu , Friedman Jay , Maruoka Yasuhiro , Ogata Fusa , Okuyama Shuhei , Clavijo Paul E. , Choyke Peter L. , Allen Clint , Kobayashi Hisataka
Published: April 2023

Supplementary Video 2. NIR-PIT effect for LLC cells. Immediately after exposure to excitation light, cellular swelling, bleb formation, and rupture of vesicles representing necrotic cell death were observed.
Supplementary Table S1 from Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors
Authors: Nagaya Tadanobu , Friedman Jay , Maruoka Yasuhiro , Ogata Fusa , Okuyama Shuhei , Clavijo Paul E. , Choyke Peter L. , Allen Clint , Kobayashi Hisataka
Published: April 2023

qPCR primers.
Supplementary Figures S1 - S9 from Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors
Authors: Nagaya Tadanobu , Friedman Jay , Maruoka Yasuhiro , Ogata Fusa , Okuyama Shuhei , Clavijo Paul E. , Choyke Peter L. , Allen Clint , Kobayashi Hisataka
Published: April 2023

Supplementary Figures S1 - S9, with legends and supplementary video captions.
Supplementary Tables from CD40 Agonist Restores the Antitumor Efficacy of Anti-PD1 Therapy in Muscle-Invasive Bladder Cancer in an IFN I/II-Mediated Manner
Authors: Leblond Marine M. , Tillé Laure , Nassiri Sina , Gilfillan Connie B. , Imbratta Claire , Schmittnaegel Martina , Ries Carola H. , Speiser Daniel E. , Verdeil Grégory
Published: April 2023

Supplementary Tables S1, S2 and S3
Supplementary Data from Intravesical Ty21a Vaccine Promotes Dendritic Cells and T Cell–Mediated Tumor Regression in the MB49 Bladder Cancer Model
Authors: Domingos-Pereira Sonia , Sathiyanadan Karthik , La Rosa Stefano , Polák Lenka , Chevalier Mathieu F. , Martel Paul , Hojeij Rim , Derré Laurent , Haefliger Jacques-Antoine , Jichlinski Patrice , Nardelli-Haefliger Denise
Published: April 2023

Supplementary Fig S1, S2, S3
Supplementary Table 3 from A Genetic Screen to Identify Gain- and Loss-of-Function Modifications that Enhance T-cell Infiltration into Tumors
Authors: Rogers Laura M. , Wang Zhaoming , Mott Sarah L. , Dupuy Adam J. , Weiner George J.
Published: April 2023

DAVID pathway analysis results
Supplementary Figure 4 from A Genetic Screen to Identify Gain- and Loss-of-Function Modifications that Enhance T-cell Infiltration into Tumors
Authors: Rogers Laura M. , Wang Zhaoming , Mott Sarah L. , Dupuy Adam J. , Weiner George J.
Published: April 2023

Proliferation of tumor cell lines in vitro is not affected by Aak1 inhibitor treatment
Supplementary Figure 2 from A Genetic Screen to Identify Gain- and Loss-of-Function Modifications that Enhance T-cell Infiltration into Tumors
Authors: Rogers Laura M. , Wang Zhaoming , Mott Sarah L. , Dupuy Adam J. , Weiner George J.
Published: April 2023

B16F0 tumor size at endpoint
Supplementary Figure 1 from A Genetic Screen to Identify Gain- and Loss-of-Function Modifications that Enhance T-cell Infiltration into Tumors
Authors: Rogers Laura M. , Wang Zhaoming , Mott Sarah L. , Dupuy Adam J. , Weiner George J.
Published: April 2023

FACS separation of CD4+ and CD8+ T cell subpopulations before sequencing and insertion site analysis
Supplementary Figure 5 from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
Authors: Lo Winifred , Parkhurst Maria , Robbins Paul F. , Tran Eric , Lu Yong-Chen , Jia Li , Gartner Jared J. , Pasetto Anna , Deniger Drew , Malekzadeh Parisa , Shelton Thomas E. , Prickett Todd , Ray Satyajit , Kivitz Scott , Paria Biman C. , Kriley Isaac , Schrump David S. , Rosenberg Steven A.
Published: April 2023

Supplementary Figure 5
Supplementary Data from Tenascin-C Orchestrates an Immune-Suppressive Tumor Microenvironment in Oral Squamous Cell Carcinoma
Authors: Spenlé Caroline , Loustau Thomas , Murdamoothoo Devadarssen , Erne William , Beghelli-de la Forest Divonne Stephanie , Veber Romain , Petti Luciana , Bourdely Pierre , Mörgelin Matthias , Brauchle Eva-Maria , Cremel Gérard , Randrianarisoa Vony , Camara Abdouramane , Rekima Samah , Schaub Sebastian , Nouhen Kelly , Imhof Thomas , Hansen Uwe , Paul Nicodème , Carapito Raphael , Pythoud Nicolas , Hirschler Aurélie , Carapito Christine , Dumortier Hélène , Mueller Christopher G. , Koch Manuel , Schenke-Layland Katja , Kon Shigeyuki , Sudaka Anne , Anjuère Fabienne , Van Obberghen-Schilling Ellen , Orend Gertraud
Published: April 2023

Supplemental Figures S1 - S7 Supplemental Tables S1 - S17
Supplementary Tables and Figures from SLAMF6 as a Regulator of Exhausted CD8+ T Cells in Cancer
Authors: Yigit Burcu , Wang Ninghai , ten Hacken Elisa , Chen Shih-Shih , Bhan Atul K. , Suarez-Fueyo Abel , Katsuyama Eri , Tsokos George C. , Chiorazzi Nicholas , Wu Catherine J. , Burger Jan A. , Herzog Roland W. , Engel Pablo , Terhorst Cox
Published: April 2023

Supplementary Tables and Figures
Supplementary Legends from SLAMF6 as a Regulator of Exhausted CD8+ T Cells in Cancer
Authors: Yigit Burcu , Wang Ninghai , ten Hacken Elisa , Chen Shih-Shih , Bhan Atul K. , Suarez-Fueyo Abel , Katsuyama Eri , Tsokos George C. , Chiorazzi Nicholas , Wu Catherine J. , Burger Jan A. , Herzog Roland W. , Engel Pablo , Terhorst Cox
Published: April 2023

Supplementary Figure legends
Supplementary Table S3 from Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer
Authors: Tomita Yusuke , Ikeda Tokunori , Sakata Shinya , Saruwatari Koichi , Sato Ryo , Iyama Shinji , Jodai Takayuki , Akaike Kimitaka , Ishizuka Shiho , Saeki Sho , Sakagami Takuro
Published: April 2023

Cox proportional hazards regression models with inverse probability of treatment weighting using propensity score.
Supplementary Figures from Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival
Authors: Danilova Ludmila , Ho Won Jin , Zhu Qingfeng , Vithayathil Teena , De Jesus-Acosta Ana , Azad Nilofer S. , Laheru Daniel A. , Fertig Elana J. , Anders Robert , Jaffee Elizabeth M. , Yarchoan Mark
Published: April 2023

Supplemental Figure S1-S4
Figure S4 from IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell
Authors: Shao Lulu , Hou Weizhou , Scharping Nicole E. , Vendetti Frank P. , Srivastava Rashmi , Roy Chandra Nath , Menk Ashley V. , Wang Yiyang , Chauvin Joe-Marc , Karukonda Pooja , Thorne Stephen H. , Hornung Veit , Zarour Hassane M. , Bakkenist Christopher J. , Delgoffe Greg M. , Sarkar Saumendra N.
Published: April 2023

Supplementary Figure S4
Figure S3 from IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell
Authors: Shao Lulu , Hou Weizhou , Scharping Nicole E. , Vendetti Frank P. , Srivastava Rashmi , Roy Chandra Nath , Menk Ashley V. , Wang Yiyang , Chauvin Joe-Marc , Karukonda Pooja , Thorne Stephen H. , Hornung Veit , Zarour Hassane M. , Bakkenist Christopher J. , Delgoffe Greg M. , Sarkar Saumendra N.
Published: April 2023

Supplementary Figure S3
Supplementary Methods from Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non–Small Cell Lung Cancer
Authors: O'Brien Shaun M. , Klampatsa Astero , Thompson Jeffrey C. , Martinez Marina C. , Hwang Wei-Ting , Rao Abishek S. , Standalick Jason E. , Kim Soyeon , Cantu Edward , Litzky Leslie A. , Singhal Sunil , Eruslanov Evgeniy B. , Moon Edmund K. , Albelda Steven M.
Published: April 2023

Description of Flow Cytometric Methods, and killing assays.
Supplementary Figures from Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non–Small Cell Lung Cancer
Authors: O'Brien Shaun M. , Klampatsa Astero , Thompson Jeffrey C. , Martinez Marina C. , Hwang Wei-Ting , Rao Abishek S. , Standalick Jason E. , Kim Soyeon , Cantu Edward , Litzky Leslie A. , Singhal Sunil , Eruslanov Evgeniy B. , Moon Edmund K. , Albelda Steven M.
Published: April 2023

Supplementary Figures 1-7